BRIEF-Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3

Reuters06-20

BRIEF-Springworks <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Expects Nirogacestat Decision From European Commission In Q3

June 20 (Reuters) - SpringWorks Therapeutics Inc SWTX.O:

SPRINGWORKS THERAPEUTICS: NIROGACESTAT DECISION FROM EUROPEAN COMMISSION EXPECTED IN Q3

Source text: ID:nGNEMyQPB

Further company coverage: SWTX.O

((( Reuters.Briefs@thomsonreuters.com );))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2544178374?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-20 21:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2544178374","market":"us","top_or_hot":-1,"title":"BRIEF-Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Springworks <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Expects Nirogacestat Decision From European Commission In Q3</title></head><body><p><span>June 20 (Reuters)</span><span> - </span>SpringWorks Therapeutics Inc <span>SWTX.O</span>:</p><ul><li><p>SPRINGWORKS THERAPEUTICS: NIROGACESTAT DECISION FROM EUROPEAN COMMISSION EXPECTED IN Q3</p></li></ul><p>Source text: <span>ID:nGNEMyQPB</span></p><p>Further company coverage: <span>SWTX.O</span></p><p> ((( Reuters.Briefs@thomsonreuters.com );))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-20 21:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Springworks <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Expects Nirogacestat Decision From European Commission In Q3</title></head><body><p><span>June 20 (Reuters)</span><span> - </span>SpringWorks Therapeutics Inc <span>SWTX.O</span>:</p><ul><li><p>SPRINGWORKS THERAPEUTICS: NIROGACESTAT DECISION FROM EUROPEAN COMMISSION EXPECTED IN Q3</p></li></ul><p>Source text: <span>ID:nGNEMyQPB</span></p><p>Further company coverage: <span>SWTX.O</span></p><p> ((( Reuters.Briefs@thomsonreuters.com );))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nFWN3SM0L5:1","article_id":"2544178374","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2544178374","pubTimestamp":1750427136,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3June 20 (Reuters) - SpringWorks Therapeutics Inc SWTX.O:SPRINGWORKS THERAPEUTICS: NIROGACESTAT DECISION FROM ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","SWTX":"SpringWorks Therapeutics, Inc."},"translate_title":"简介-Springworks Therapeutics预计欧盟委员会将在第三季度做出Nirogacestat决定","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SWTX":0.9},"content_text":"BRIEF-Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3June 20 (Reuters) - SpringWorks Therapeutics Inc SWTX.O:SPRINGWORKS THERAPEUTICS: NIROGACESTAT DECISION FROM EUROPEAN COMMISSION EXPECTED IN Q3Source text: ID:nGNEMyQPBFurther company coverage: SWTX.O ((( Reuters.Briefs@thomsonreuters.com );))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2544178374","isCrawlerRequest":true}